Moderna reports unexpected profit due to higher sales of COVID vaccine
Moderna on Thursday reported an unexpected third-quarter profit, driven by cost cuts and better-than-expected sales of its COVID-19 vaccine, even though revenue from its new respiratory syncytial virus vaccine was low.
ПОПУЛЯРНЫЕ ПОСТЫ
Pope warns of imbalance in Vatican pension fund
Ноябрь 22, 2024
Angela Merkel to publish her memoirs
Ноябрь 22, 2024
Thousands left without power in Washington State
Ноябрь 21, 2024
Eight times as many children will face extreme heatwaves in 2050
Ноябрь 21, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ